LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION

STUDY OF THE APPEARANCE OF LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION

Prospective, observational, multicenter study that will evaluate the changes in lung function that patients admitted with SARS-CoV-2 pneumonia will present according to the level of severity at 4, 12, 26 and 52 weeks after hospital discharge.

The project consists of a prospective, observational, multicenter study that will evaluate changes in lung function (forced spirometry, measurement of static lung volumes using plethysmography and pulmonary carbon monoxide diffusion test) that patients admitted with pneumonia will present. caused by SARS-CoV-2 according to the level of severity at 4, 12, 26 and 52 weeks after discharge from hospital. Restrictive pulmonary abnormalities will be confirmed by imaging tests (high resolution chest CT).

Inclusion Criteria:

• Patients admitted for bilateral pneumonia caused by SARS-CoV-2 (confirmed by PCR).
• Age over 18 years.
• Acceptance of informed consent.
• Life expectancy over 1 year.

Exclusion Criteria:

• Patients with a previous diagnosis of interstitial lung disease.
• Inability to attend review visits.